Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Boggione

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Case Reports|November 25, 2020
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemiaRiccardo Moia, Mariangela Greco, Paola Boggione, et al.
Expert Opinion on Therapeutic Targets|October 5, 2020
Targeting p53 in chronic lymphocytic leukemiaRiccardo Moia, Paola Boggione, Abdurraouf Mokhtar Mahmoud, et al.
International Journal of Molecular Sciences|April 3, 2021
Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult HematologistsElena Crisà, Paola Boggione, Maura Nicolosi, et al.
Frontiers in Oncology|November 12, 2021
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher <i>JAK2</i> Allele Burden in Patients With Myeloproliferative NeoplasmsRiccardo Moia, Micol Giulia Cittone, Paola Boggione, et al.
British Journal of Haematology|December 26, 2021
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironmentElena Boggio, Casimiro Luca Gigliotti, Riccardo Moia, et al.
British Journal of Haematology|July 13, 2022
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Donatella Talotta, Mohammad Almasri, et al.
Frontiers in Oncology|August 19, 2021
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic LeukemiaFortunato Morabito, Giovanni Tripepi, Riccardo Moia, et al.
Frontiers in Oncology|April 4, 2022
Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE PlatformFabio Efficace, Andrea Patriarca, Mario Luppi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Case Reports|November 25, 2020
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemiaRiccardo Moia, Mariangela Greco, Paola Boggione, et al.
Expert Opinion on Therapeutic Targets|October 5, 2020
Targeting p53 in chronic lymphocytic leukemiaRiccardo Moia, Paola Boggione, Abdurraouf Mokhtar Mahmoud, et al.
International Journal of Molecular Sciences|April 3, 2021
Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult HematologistsElena Crisà, Paola Boggione, Maura Nicolosi, et al.
Frontiers in Oncology|November 12, 2021
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher <i>JAK2</i> Allele Burden in Patients With Myeloproliferative NeoplasmsRiccardo Moia, Micol Giulia Cittone, Paola Boggione, et al.
British Journal of Haematology|December 26, 2021
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironmentElena Boggio, Casimiro Luca Gigliotti, Riccardo Moia, et al.
British Journal of Haematology|July 13, 2022
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Donatella Talotta, Mohammad Almasri, et al.
Frontiers in Oncology|August 19, 2021
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic LeukemiaFortunato Morabito, Giovanni Tripepi, Riccardo Moia, et al.
Frontiers in Oncology|April 4, 2022
Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE PlatformFabio Efficace, Andrea Patriarca, Mario Luppi, et al.
Pageof 1